发明名称 5-HT6 RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF INSULIN-RELATED DISORDERS
摘要 <p>The present invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a candidate compound with a 5-HT6 receptor, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound. In addition, the invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a single dose of a candidate compound with a 5-HT6 receptor, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound. Further, the invention relates to a method for identifying a glycemic stabilizing compound, by: a) contacting a candidate compound with a 5-HT6 receptor in an isolated cell, b) determining whether 5-HT6 receptor functionality is increased, and c) determining whether a glycemic marker is directly modulated, where an increase in 5-HT6 receptor functionality and direct modulation of a glycemic marker identifies the candidate compound as the glycemic stabilizing compound.</p>
申请公布号 WO2010011305(A1) 申请公布日期 2010.01.28
申请号 WO2009US04247 申请日期 2009.07.22
申请人 ARENA PHARMACEUTICALS, INC.;LEONARD, JAMES, N.;CHU, ZHI-LIANG;SMITH, BRIAN, M. 发明人 LEONARD, JAMES, N.;CHU, ZHI-LIANG;SMITH, BRIAN, M.
分类号 G01N33/48;G01N33/50 主分类号 G01N33/48
代理机构 代理人
主权项
地址